<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id><journal-title>BMC Medical Genetics</journal-title><issn pub-type="epub">1471-2350</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2350-9-1</article-id><article-id pub-id-type="pmid">18179706</article-id><article-id pub-id-type="doi">10.1186/1471-2350-9-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title><italic>C4B </italic>null alleles are not associated with genetic polymorphisms in the adjacent gene <italic>CYP21A2 </italic>in autism</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Sweeten</surname><given-names>Thayne L</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>thayne@cpd2.usu.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Odell</surname><given-names>Daniel W</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>dan@cpd2.usu.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Odell</surname><given-names>J Dennis</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dennis@cpd2.usu.edu</email></contrib><contrib id="A4" corresp="yes" contrib-type="author"><name><surname>Torres</surname><given-names>Anthony R</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rtorres@cpd2.usu.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Center for Persons with Disabilities, Utah State University, 6895 Old Main Hill, Logan, UT 84322-6895, USA</aff><aff id="I2"><label>2</label>Department of Biological Engineering, Utah State University, 4105 Old Main Hill, Logan, UT 84322-4105, USA</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>7</day><month>1</month><year>2008</year></pub-date><volume>9</volume><fpage>1</fpage><lpage>1</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/9/1"/><history><date date-type="received"><day>1</day><month>8</month><year>2007</year></date><date date-type="accepted"><day>7</day><month>1</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Sweeten et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Sweeten et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Sweeten L Thayne thayne@cpd2.usu.edu </dc:author><dc:title> C4B null alleles are not associated with genetic polymorphisms in the adjacent gene CYP21A2 in autism </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 9(1): 1-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2008)9:1&#x0003c;1&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Research indicates that the etiology of autism has a strong genetic component, yet so far the search for genes that contribute to the disorder, including several whole genome scans, has led to few consistent findings. However, three studies indicate that the complement <italic>C4B </italic>gene null allele (i.e. the missing or nonfunctional <italic>C4B </italic>gene) is significantly more frequent in individuals with autism. Due to the close proximity of the <italic>CYP21A2 </italic>gene to the <italic>C4B </italic>locus (3 kb) it was decided to examine samples from autistic subjects, including many with known <italic>C4B </italic>null alleles for common <italic>CYP21A2 </italic>mutations.</p></sec><sec sec-type="methods"><title>Methods</title><p>Samples from subjects diagnosed with autism and non-autistic controls (controls) previously typed for <italic>C4B </italic>null alleles were studied. Allele specific polymerase chain reaction (PCR) methods were used to determine 8 of the most common <italic>CYP21A2 </italic>genetic mutations, known to completely or partially inhibit 21-hydroxylase, the enzyme encoded by the <italic>CYP21A2 </italic>gene.</p></sec><sec><title>Results</title><p>Although the combined autism and control study subjects had 50 <italic>C4B </italic>null alleles only 15 <italic>CYP21A2 </italic>mutations were detected in over 2250 genotypes. Eight mutations were detected in the autistic samples and 7 in the controls. The frequency of <italic>CYP21A2 </italic>mutations was similar between the autism and control samples. Only one individual (autistic) carried a chromosome containing both <italic>C4B </italic>null allele and <italic>CYP21A2 </italic>mutations.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Autism is a severe neurodevelopmental disorder that is approximately four times more common in males than females. The current prevalence for the disorder is approximately 1 in 152 children [<xref ref-type="bibr" rid="B1">1</xref>]. Although there are various mechanisms that can lead to this behaviorally defined condition, in most cases the etiology remains unknown. A strong genetic component clearly exists [<xref ref-type="bibr" rid="B2">2</xref>]; however, consistent detection of disease associated genetic variants has rarely been reported. Whole genome scans using microarray technology may better detect the genetic contributions to autism susceptibility [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Genes located in the RCCX module found on chromosome 6 in the human leukocyte antigen (HLA) locus are associated with various disease states [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. This module contains the genes <italic>RP, C4, CYP21</italic>, and <italic>TNX </italic>(abbreviated RCCX) in a contiguous sequence. Different variants of these four genes can exist in the RCCX module including <italic>RP1 </italic>or <italic>RP2, C4A </italic>or <italic>C4B </italic>(long or short), <italic>CYP21A2 </italic>or <italic>CYP21A1P</italic>, and <italic>TNXA </italic>or <italic>TNXB</italic>. <italic>RP2 </italic>and <italic>TNXA </italic>are gene fragments while <italic>CYP21A1P </italic>is a pseudogene. A single chromosome usually contains one, two, three RCCX modules in tandem, but rare cases can have four modules.</p><p>Because of the diversity in the number and size of the RCCX modules misalignments and unequal crossovers occur during meiosis resulting frequently in deletions, conversions, duplications along with the acquisition of mutations from nearby pseudogenes or gene segments [<xref ref-type="bibr" rid="B6">6</xref>]. One such mutation in this module is the missing/nonfunctional <italic>C4A </italic>or <italic>C4B </italic>gene (<italic>C4 </italic>null allele). Therefore, the <italic>C4 </italic>containing complex is an extraordinarily complex region of the human genome [<xref ref-type="bibr" rid="B7">7</xref>] (Figure <xref ref-type="fig" rid="F1">1</xref>).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Three common arrangements of the RCCX module</bold>. Monomodular, bimodular, and trimodular are present in about 17, 69 and 14% of chromosomes, respectively [7]. The <italic>C4 </italic>gene which is either <italic>C4A </italic>or <italic>C4B </italic>can be either a long or short variant depending upon the presence of a 6.36 kb endogenous retrovirus, <italic>HERV-K(C4)</italic>. Pseudogenes or gene fragments are red. <italic>CYP21A1* </italic>indicates either a <italic>CYP21A1P </italic>pseudogene or the <italic>CYP21A2 </italic>gene. In the present study 40 chromosomes from autistic individuals had a <italic>C4B </italic>null allele. Of these chromosomes 19 were monomodular and 21 were bimodular. In the control subjects with <italic>C4B </italic>null alleles 10 chromosomes were monomodular and 1 was bimodular. Bimodular <italic>C4B </italic>null alleles were significantly more frequent in autistic subjects compared to controls (P = 0.0001). No <italic>C4B </italic>null alleles or <italic>CYP21A2 </italic>mutations were detected in the subjects (2 autistic, 4 control) with trimodular RCCX modules, determined by protein immunofixation electrophoresis [10].</p></caption><graphic xlink:href="1471-2350-9-1-1"/></fig><p>The RCCX module may play a significant role in the genetic underpinnings of autism. Several studies have shown that the frequency of <italic>C4B </italic>null alleles is increased in individuals with autism [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>], the most recent of which found that 42.4% of autistic subjects carry a <italic>C4B </italic>null allele compared to 14.5% of controls [<xref ref-type="bibr" rid="B10">10</xref>]. The <italic>CYP21A2 </italic>gene is located approximately 3 kb downstream of <italic>C4 </italic>and the concurrent deletion of <italic>C4B </italic>with portions of the <italic>CYP21A2 </italic>has been described [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Therefore, the aim of the present research was to determine if the <italic>C4B </italic>null allele, found frequently in subjects with autism, is associated with <italic>CYP21A2 </italic>mutations. As well, the overall frequency of <italic>CYP21A2 </italic>mutations in autistic verses control subjects was determined.</p><p><italic>C4 </italic>genes encode innate immune C4 proteins that are important in the complement cascade. <italic>CYP21A2 </italic>encodes an enzyme, 21-hydroxylase, which is important in the synthesis of cortisol and in maintaining proper androgen levels.</p><p>Over 2,250 genetic typings of <italic>CYP21A2 </italic>mutations were completed in 80 autistic and 60 controls subjects that had previously been typed for <italic>C4B </italic>null alleles [<xref ref-type="bibr" rid="B10">10</xref>]. Fifteen total <italic>CYP21A2 </italic>mutations where detected; however, only one individual (autistic) carried a chromosome containing both a <italic>C4B </italic>null allele and <italic>CYP21A2 </italic>mutations. Therefore, in these subjects it does not appear that <italic>C4B </italic>null alleles are associated with the <italic>CYP21A2 </italic>mutations studied.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>This study utilized samples previously characterize for <italic>C4A </italic>and <italic>C4B </italic>null alleles in an autism case-control study [<xref ref-type="bibr" rid="B10">10</xref>]. Autistic subjects and controls were Caucasian of Northern European descent and IRB (Utah State University) approval was obtained for this study. As reported, the subjects were diagnosed with autism using DSM-IV criteria by pediatric psychiatrists and psychologists expert in the evaluation of autism. The Autism Diagnostic Observation Schedule (ADOS) [<xref ref-type="bibr" rid="B13">13</xref>] and the Autism Diagnostic Inventory (ADI) [<xref ref-type="bibr" rid="B14">14</xref>] confirmed the Diagnosis. Various CYP21A2 genetic determinations were completed in 80 individuals with autism (8 female, 72 male) and 60 control subjects (15 female, 45 male). Parents of the particular subjects were typed if their child was positive for a mutation.</p></sec><sec><title>DNA preparation</title><p>DNA samples were extracted from peripheral blood mononuclear cells as previously described [<xref ref-type="bibr" rid="B15">15</xref>]. To genotype samples with limited amounts of DNA, whole genome amplification was performed using multiple displacement amplification (MDA) based on the method of Dean <italic>et al.</italic>[<xref ref-type="bibr" rid="B16">16</xref>]. MDA was performed using RepliPHI&#x02122; Phi 29 Reagent Sets (Epicentre<sup>&#x000ae;</sup>Technologies, Madison, Wisconsin).</p><p>PicoGreen<sup>&#x000ae; </sup>quantitation of amplified DNA was performed using a Quant-iT&#x02122; DNA Assay Kit from Molecular Probes&#x02122; (Eugene, Oregon) according to kit protocol. Fluorescence was measured with a Synergy HT microplate reader (BIO-TEK<sup>&#x000ae;</sup>, Winooski, Vermont).</p></sec><sec><title>Polymerase chain reaction</title><p>Seven mutations were determined by allele-specific polymerase chain reaction (PCR) based on the method of Wilson <italic>et al.</italic>[<xref ref-type="bibr" rid="B17">17</xref>]. This method is as accurate as the dot blot procedure [<xref ref-type="bibr" rid="B17">17</xref>]; therefore, it is sensitive enough to detect a mutation in only one <italic>CYP21A2 </italic>gene if more than two copies of the gene are present. The mutations analyzed included amino acid substitutions (P30L, I172N, V281L, R356W, exon 6 cluster mutation (L236N, V237Q, M239K)), a splicing mutation (intron 2 (656) A/C to G), and a deletion (exon 3, 8 base pair deletion). Each reaction contained a primer specific for either the common or rare genetic variant in conjunction with a primer that amplified only the <italic>CYP21A2 </italic>gene and not the pseudogene (Table <xref ref-type="table" rid="T1">1</xref>). A PCR based assay for detection of a 30 kb deletion/conversion affecting both <italic>C4B </italic>and <italic>CYP21A2 </italic>was performed based upon the method described in Keen-Kim <italic>et al.</italic>[<xref ref-type="bibr" rid="B18">18</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Sequences of oligonucleotide primers for allele-specific PCR</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>CYP21A2 Mutations [ref]</bold></td><td align="left"><bold>rs #</bold></td><td align="left"><bold>Primer</bold></td><td align="left"><bold>5'-Sequence-3'</bold></td></tr></thead><tbody><tr><td align="left">30 kb deletion [18]</td><td></td><td align="left">common forward</td><td align="left">gcttcttgatgggtgatcaat</td></tr><tr><td></td><td></td><td align="left">rare forward</td><td align="left">tccccaatccttactttttgtc</td></tr><tr><td></td><td></td><td align="left">reverse</td><td align="left">cctcaatcctctgcagcg</td></tr><tr><td align="left">V281L [17]</td><td align="left">rs6471</td><td align="left">common reverse</td><td align="left">tccactgcagccatgtgcac</td></tr><tr><td></td><td></td><td align="left">rare reverse</td><td align="left">tccactgcagccatgtgcaa</td></tr><tr><td></td><td></td><td align="left">forward</td><td align="left">gagggatcacatcgtcgtggagatg</td></tr><tr><td align="left">I172N [17]</td><td align="left">rs34607927</td><td align="left">common forward</td><td align="left">tcctcacctgcagcatcat</td></tr><tr><td></td><td></td><td align="left">rare forward</td><td align="left">ctctcctcacctgcagcatcaa</td></tr><tr><td></td><td></td><td align="left">reverse</td><td align="left">agctgcatctccacgatgtga</td></tr><tr><td align="left">R356W [17]</td><td></td><td align="left">common reverse</td><td align="left">ctaagggcacaacgggccg</td></tr><tr><td></td><td></td><td align="left">rare reverse</td><td align="left">ctaagggcacaacgggcca</td></tr><tr><td></td><td></td><td align="left">forward</td><td align="left">gagggatcacatcgtcgtggagatg</td></tr><tr><td align="left">P30L [17]</td><td></td><td align="left">common forward</td><td align="left">tccggagcctccacctccc</td></tr><tr><td></td><td></td><td align="left">rare forward</td><td align="left">tccggagcctccacctcct</td></tr><tr><td></td><td></td><td align="left">reverse</td><td align="left">agctgcatctccacgatgtga</td></tr><tr><td align="left">IN2 (656) A/C to G [17]</td><td></td><td align="left">common forward (A)</td><td align="left">ttcccaccctccagcccccaa</td></tr><tr><td></td><td></td><td align="left">common forward (C)</td><td align="left">ttcccaccctccagcccccac</td></tr><tr><td></td><td></td><td align="left">rare forward</td><td align="left">ttcccaccctccagcccccag</td></tr><tr><td></td><td></td><td align="left">reverse</td><td align="left">agctgcatctccacgatgtga</td></tr><tr><td align="left">Ex 3 (8 bp deletion) [17]</td><td></td><td align="left">common forward</td><td align="left">cggacctgtccttgggagactac</td></tr><tr><td></td><td></td><td align="left">rare forward</td><td align="left">actacccggacctgtccttggtc</td></tr><tr><td></td><td></td><td align="left">reverse</td><td align="left">agctgcatctccacgatgtga</td></tr><tr><td align="left">Ex 6 cluster</td><td></td><td align="left" colspan="2">(see reference 17 for further description)</td></tr><tr><td align="left">&#x02003;L236N</td><td></td><td align="left">common reverse</td><td align="left">agctgcatctccacgatgtga</td></tr><tr><td align="left">&#x02003;V237Q</td><td align="left">rs12530380</td><td align="left">rare reverse</td><td align="left">tcagctgcttctcctcgttgtgg</td></tr><tr><td align="left">&#x02003;M239K</td><td align="left">rs6476</td><td align="left">forward</td><td align="left">cggacctgtccttgggagactac</td></tr></tbody></table></table-wrap></sec><sec><title>Statistics</title><p>Chi-square analysis along with the Fisher's Exact Test where performed using SPSS 14 (SPSS Inc., Chicago, Illinois). A two-tailed test with a P-value of &#x0003c; 0.05 was considered significant after Bonferoni corrections for multiple comparisons.</p></sec></sec><sec><title>Results and discussion</title><p>Although the 80 autistic individuals studied had 40 <italic>C4B </italic>null alleles and the 60 control individuals had 10 <italic>C4B </italic>null alleles only 15 total <italic>CYP21A2 </italic>mutations were detected in over 2250 genotypes. Eight <italic>CYP21A2 </italic>mutations were detected in the autistic subjects and 7 in the controls (Table <xref ref-type="table" rid="T2">2</xref>). Only one individual (autistic) had a chromosome carrying both a <italic>C4B </italic>null allele and a <italic>CYP21A2 </italic>mutation. Therefore, no association was determined between <italic>C4B </italic>null alleles and <italic>CYP21A2 </italic>mutations in the study subjects.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Frequencies of the <italic>C4B </italic>null allele and <italic>CYP21A2 </italic>mutations</p></caption><table frame="hsides" rules="groups"><tbody><tr><td></td><td align="left"><bold>Autism</bold></td><td align="left"><bold>Control</bold></td><td align="left"><bold>P-value</bold></td></tr><tr><td></td><td colspan="3"><hr></hr></td></tr><tr><td align="left"><italic>C4B </italic>null allele</td><td align="left">40/160</td><td align="left">10/120</td><td align="left">P = 0.0003</td></tr><tr><td align="left">30 kb deletion/conversion</td><td align="left">1/160</td><td align="left">2/120</td><td align="left">Not significant (NS)</td></tr><tr><td></td><td></td><td></td><td></td></tr><tr><td align="left"><italic>CYP21A2 </italic>mutations</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;V281L</td><td align="left">3/160</td><td align="left">1/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;I172N</td><td align="left">1/160</td><td align="left">2/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;R356W</td><td align="left">1/160</td><td align="left">0/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;P30L</td><td align="left">2/160</td><td align="left">1/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;IN2</td><td align="left">0/160</td><td align="left">0/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;Ex 3 Del</td><td align="left">0/160</td><td align="left">1/120</td><td align="left">NS</td></tr><tr><td align="left">&#x02003;Ex 6 cluster</td><td align="left">0/160</td><td align="left">0/120</td><td align="left">NS</td></tr></tbody></table></table-wrap><p>Overall, the number of <italic>CYP21A2 </italic>mutations did not differ between the autism and control groups and no group differences were found in frequencies of individual <italic>CYP21A2 </italic>mutations. The frequency of <italic>CYP21A2 </italic>mutations seen in this research is similar to general population frequencies reported by others [<xref ref-type="bibr" rid="B19">19</xref>]. Five individuals with autism (6.25%) and five controls (8.33%) carried a <italic>CYP21A2 </italic>mutation. Two individuals with autism and one control subject carried two or three mutations. In these cases the mutations all typed to individual parents. Thus, the multiple mutations were found on single chromosomes. When a mutation was found in the child's DNA it was also present in DNA from one of the parents, thus confirming both accurate typing and absence of de novo mutations in the study children.</p><p>HLA extended haplotyes known to contain <italic>C4B </italic>null alleles are increased in frequency in autistic individuals (i.e. HLA extended haplotypes 35.2 (n = 4), 35.3 (n = 2), 44.1 (n = 8), and 58.1 (n = 1)). Extended haplotypes 35.3 and 58.1 have monomodular RCCX structures (<italic>C4A</italic>: <italic>C4B </italic>null allele) and extended haplotypes 35.2 and 44.1 are bimodular (<italic>C4A</italic>, <italic>C4A</italic>:<italic>C4B </italic>null allele). No <italic>CYP21A2 </italic>mutations were observed in these haplotypes.</p><p>The HLA 8.1 is present in 10% of the Caucasian population and represents the most common extended haplotype. It has a monomodular RCCX structure with a <italic>C4A </italic>null allele and a normal <italic>C4B </italic>gene (<italic>C4A </italic>null allele: <italic>C4B</italic>). This extended haplotype, referred to as COX in the MHC Haplotype Project [<xref ref-type="bibr" rid="B20">20</xref>], has been completely sequenced [<xref ref-type="bibr" rid="B21">21</xref>]. Of the eighteen subjects with an 8.1 extended haplotype one had the rare SNP creating the TTG codon that encodes for leucine at position 281 while 17 subjects had the common codon GTG that encodes for valine at position 281. This observation is in agreement with DNA sequencing data that shows low level SNP diversity in 8.1 extended haplotypes from different individuals [<xref ref-type="bibr" rid="B22">22</xref>].</p><p>The specific <italic>CYP21A2 </italic>mutations were chosen because they are the most common mutations that result in significant decreases in 21-hydroxylase activity. One of the mutations investigated was a 30 kb deletion/conversion that deletes <italic>C4B </italic>and converts <italic>CYP21A2 </italic>into a nonfunctional <italic>CYP21A1P/CYP21A2 </italic>hybrid with its pseudogene (Figure <xref ref-type="fig" rid="F2">2</xref>). This mutation was of particular interest because it provides a direct link between a <italic>C4B </italic>null allele and a <italic>CYP21A2 </italic>mutation. One autistic subject and two controls carried this mutation. Again, these three polymorphisms were inherited and did not involve de novo mutations.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>The 30 kb deletion/conversion of <italic>C4B </italic>and <italic>CYP21A2</italic></bold>. This diagram depicts the most common arrangement of the <italic>RP, C4, CYP21</italic>, and <italic>TNX </italic>(RCCX) gene module. Pseudogenes or gene fragments are red. The 30 kb deletion removes part of <italic>CYP21A1P, TNXA, RP2, C4B </italic>and part of <italic>CYP21A2 </italic>leaving a non-protein encoding <italic>CYP21A1P/CYP21A2 </italic>region.</p></caption><graphic xlink:href="1471-2350-9-1-2"/></fig><p>It has been reported that two of the mutations, P30L and V281L, partially inhibit 21-hydroxylase activity (30&#x02013;60% of normal), whereas the other mutations analyzed cause either complete or nearly complete enzyme inhibition [<xref ref-type="bibr" rid="B23">23</xref>]. Four subjects with autism (5%) carried a partially inhibiting mutation (P30L or V281L) compared to two control subjects (3.33%). This difference is not statistically significant.</p><p>21-hydroxylase deficiency is the most common cause of congenital adrenal hyperplasia. Some evidence supports the idea of 21-hydroxylase being involved in autism [<xref ref-type="bibr" rid="B24">24</xref>], which could result in the excessive androgen production seen in some cases [<xref ref-type="bibr" rid="B25">25</xref>] and thereby contribute to disease etiology [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. The present data does not provide genetic support for 21-hydroxylase involvement in autism.</p></sec><sec><title>Conclusion</title><p>This study examined both mono and bimodular RCCX genetic modules that contain <italic>C4B </italic>null alleles for mutations in the adjoining <italic>CYP21A2 </italic>gene. The <italic>C4B </italic>null alleles seen in autism are not associated with the <italic>CYP21A2 </italic>genetic mutations examined in this study. The frequency of <italic>CYP21A2 </italic>mutations was similar between the autism and control groups. Based on family typings no de novo mutations of <italic>C4B </italic>or <italic>CYP21A2 </italic>were apparent in study subjects. Therefore, the <italic>CYP21A2 </italic>mutations studied do not appear to contribute to the etiology of autism. However, a role for <italic>CYP21A2 </italic>in autism cannot be ruled out as other factors affecting <italic>CYP21A2 </italic>gene expression such as promoter polymorphisms or epigenetic variation were not studied and may be relevant [<xref ref-type="bibr" rid="B28">28</xref>]. As well, a weak association may be beyond the statistical power of the present study to detect.</p></sec><sec><title>Competing interests</title><p>The author(s) declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>DWO aided in the molecular genetic studies. JDO assigned the C4 typing. ART aided in the study design and assays, coordination the research and helped to draft the manuscript. TLS conceived of the study, carried out the molecular genetic studies, participated in the design, performed the statistical analysis and drafted the manuscript. All authors have read and approved the final manuscript.</p></sec><sec><title>Pre-publication history</title><p>The pre-publication history for this paper can be accessed here:</p><p><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/9/1/prepub"/></p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This research project was supported with funding from The Jonty Foundation and the Center for Persons with Disabilities (Utah State University). We would like to thank Dr. Dave Ward (Nevada Cancer Institute) and Dr. Jonna Westover (CPD) for their suggestions and aid in preparing the manuscript.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><collab>Autism and Developmental Disabilities Monitoring Network Surveillance year 2002 Principal Investigators; Centers for Disease Control and Prevention</collab></person-group><article-title>Prevalence of autism spectrum disorders&#x02013;autism and developmental disabilities monitoring network, 14 sites, United States, 2002</article-title><source>MMWR Surveill Summ</source><year>2007</year><volume>56</volume><fpage>12</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">17287715</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Folstein</surname><given-names>S</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name></person-group><article-title>Infantile autism: a genetic study of 21 twin pairs</article-title><source>J Child Psychol Psychiatry</source><year>1977</year><volume>18</volume><fpage>297</fpage><lpage>321</lpage><pub-id pub-id-type="pmid">562353</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-7610.1977.tb00443.x</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jacquemont</surname><given-names>ML</given-names></name><name><surname>Sanlaville</surname><given-names>D</given-names></name><name><surname>Redon</surname><given-names>R</given-names></name><name><surname>Raoul</surname><given-names>O</given-names></name><name><surname>Cormier-Daire</surname><given-names>V</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Amiel</surname><given-names>J</given-names></name><name><surname>Le Merrer</surname><given-names>M</given-names></name><name><surname>Heron</surname><given-names>D</given-names></name><name><surname>de Blois</surname><given-names>MC</given-names></name><name><surname>Prieur</surname><given-names>M</given-names></name><name><surname>Vekemans</surname><given-names>M</given-names></name><name><surname>Carter</surname><given-names>NP</given-names></name><name><surname>Munnich</surname><given-names>A</given-names></name><name><surname>Colleaux</surname><given-names>L</given-names></name><name><surname>Philippe</surname><given-names>A</given-names></name></person-group><article-title>Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders</article-title><source>J Med Genet</source><year>2006</year><volume>43</volume><fpage>843</fpage><lpage>849</lpage><pub-id pub-id-type="pmid">16840569</pub-id><pub-id pub-id-type="doi">10.1136/jmg.2006.043166</pub-id></citation></ref><ref id="B4"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Chung</surname><given-names>EK</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lhotta</surname><given-names>K</given-names></name><name><surname>Hebert</surname><given-names>LA</given-names></name><name><surname>Birmingham</surname><given-names>DJ</given-names></name><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Yu</surname><given-names>CY</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Tsokos GC</surname></name></person-group><article-title>The intricate role of complement componenet C4 in human systemic lupus erythematosus</article-title><source>Complement in Autoimmunity</source><year>2004</year><publisher-name>Basel, Karger</publisher-name><fpage>98</fpage><lpage>132</lpage></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>PC</given-names></name><name><surname>New</surname><given-names>MI</given-names></name><name><surname>Dupont</surname><given-names>B</given-names></name></person-group><article-title>HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation</article-title><source>Proc Natl Acad Sci USA</source><year>1984</year><volume>81</volume><fpage>7505</fpage><lpage>7509</lpage><pub-id pub-id-type="pmid">6334310</pub-id><pub-id pub-id-type="doi">10.1073/pnas.81.23.7505</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Mendoza</surname><given-names>AR</given-names></name><name><surname>Welch</surname><given-names>TR</given-names></name><name><surname>Zipf</surname><given-names>WB</given-names></name><name><surname>Yu</surname><given-names>CY</given-names></name></person-group><article-title>Modular variations of the human major histocompatibility complex class III genes for serine/threonine kinase RP, complement component C4, steroid 21-hydroxylase CYP21, and tenascin TNX (the RCCX module)</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>12147</fpage><lpage>12156</lpage><pub-id pub-id-type="pmid">10207042</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.17.12147</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchong</surname><given-names>CA</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pupert</surname><given-names>KL</given-names></name><name><surname>Chung</surname><given-names>EK</given-names></name><name><surname>Jones</surname><given-names>KN</given-names></name><name><surname>Sotos</surname><given-names>JF</given-names></name><name><surname>William</surname><given-names>BZ</given-names></name><name><surname>Rennebohm</surname><given-names>RM</given-names></name><name><surname>Yu</surname><given-names>CY</given-names></name></person-group><article-title>Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) nodules in Caucasians: the load of RCCX genetic diversity on major histocompatibility complex-associated disease</article-title><source>J Exp Med</source><year>2000</year><volume>191</volume><fpage>2183</fpage><lpage>2196</lpage><pub-id pub-id-type="pmid">10859342</pub-id><pub-id pub-id-type="doi">10.1084/jem.191.12.2183</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>RP</given-names></name><name><surname>Singh</surname><given-names>VK</given-names></name><name><surname>Cole</surname><given-names>P</given-names></name><name><surname>Odell</surname><given-names>JD</given-names></name><name><surname>Pingree</surname><given-names>CB</given-names></name><name><surname>Warren</surname><given-names>WL</given-names></name></person-group><article-title>Increased frequency of the null allele at the complement C4b locus in autism</article-title><source>Clin Exp Immunol</source><year>1991</year><volume>83</volume><fpage>438</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">2004485</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>RP</given-names></name><name><surname>Singh</surname><given-names>VK</given-names></name><name><surname>Averett</surname><given-names>RE</given-names></name><name><surname>Odell</surname><given-names>JD</given-names></name><name><surname>Maciulis</surname><given-names>A</given-names></name><name><surname>Burger</surname><given-names>RA</given-names></name><name><surname>Daniels</surname><given-names>WW</given-names></name><name><surname>Warren</surname><given-names>WL</given-names></name></person-group><article-title>Immunogenetic studies in autism and related disorders</article-title><source>Mol Chem Neuropathol</source><year>1996</year><volume>28</volume><fpage>77</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">8871944</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odell</surname><given-names>D</given-names></name><name><surname>Maciulis</surname><given-names>A</given-names></name><name><surname>Cutler</surname><given-names>A</given-names></name><name><surname>Warren</surname><given-names>L</given-names></name><name><surname>McMahon</surname><given-names>W</given-names></name><name><surname>Coon</surname><given-names>H</given-names></name><name><surname>Stubbs</surname><given-names>G</given-names></name><name><surname>Henley</surname><given-names>K</given-names></name><name><surname>Torres</surname><given-names>A</given-names></name></person-group><article-title>Confirmation of the association of the C4B null allele in autism</article-title><source>Hum Immunol</source><year>2005</year><volume>66</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">15694999</pub-id><pub-id pub-id-type="doi">10.1016/j.humimm.2004.11.002</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname><given-names>MC</given-names></name><name><surname>Palsdottir</surname><given-names>A</given-names></name><name><surname>Belt</surname><given-names>KT</given-names></name><name><surname>Porter</surname><given-names>RR</given-names></name></person-group><article-title>Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region</article-title><source>EMBO J</source><year>1985</year><volume>4</volume><fpage>2547</fpage><lpage>2552</lpage><pub-id pub-id-type="pmid">2996881</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>PM</given-names></name><name><surname>Carroll</surname><given-names>MC</given-names></name><name><surname>Alper</surname><given-names>CA</given-names></name><name><surname>Rittner</surname><given-names>C</given-names></name><name><surname>Whitehead</surname><given-names>AS</given-names></name><name><surname>Yunis</surname><given-names>EJ</given-names></name><name><surname>Colten</surname><given-names>HR</given-names></name></person-group><article-title>Polymorphism of the human complement C4 and steroid 21-hydroxylase genes: restriction fragment length polymorphisms revealing structural deletions, homoduplications, and size variants</article-title><source>J Clin Invest</source><year>1986</year><volume>78</volume><fpage>650</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">3018042</pub-id><pub-id pub-id-type="doi">10.1172/JCI112623</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>C</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name><name><surname>Goode</surname><given-names>S</given-names></name><name><surname>Heemsbergen</surname><given-names>J</given-names></name><name><surname>Jordan</surname><given-names>H</given-names></name><name><surname>Mawhood</surname><given-names>L</given-names></name><name><surname>Schopler</surname><given-names>E</given-names></name></person-group><article-title>The autism diagnostic observation schedule: A standardized observation of communicative and social behavior</article-title><source>J Autism Dev Disord</source><year>1989</year><volume>19</volume><fpage>185</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">2745388</pub-id><pub-id pub-id-type="doi">10.1007/BF02211841</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>LeCouteur</surname><given-names>A</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name><name><surname>Lord</surname><given-names>C</given-names></name><name><surname>Rios</surname><given-names>P</given-names></name><name><surname>Robertson</surname><given-names>S</given-names></name><name><surname>Holdgrafer</surname><given-names>M</given-names></name><name><surname>McLennan</surname><given-names>JD</given-names></name></person-group><article-title>Autism Diagnostic Interview: A semistructured interview for parents and caregivers of autistic persons</article-title><source>J Autism Dev Disord</source><year>1989</year><volume>19</volume><fpage>363</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">2793783</pub-id><pub-id pub-id-type="doi">10.1007/BF02212936</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>AR</given-names></name><name><surname>Maciulis</surname><given-names>A</given-names></name><name><surname>Stubbs</surname><given-names>EG</given-names></name><name><surname>Cutler</surname><given-names>A</given-names></name><name><surname>Odell</surname><given-names>D</given-names></name></person-group><article-title>The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder</article-title><source>Hum Immunol</source><year>2002</year><volume>63</volume><fpage>311</fpage><lpage>316</lpage><pub-id pub-id-type="pmid">12039413</pub-id><pub-id pub-id-type="doi">10.1016/S0198-8859(02)00374-9</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dean</surname><given-names>FB</given-names></name><name><surname>Hosono</surname><given-names>S</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Faruqi</surname><given-names>AF</given-names></name><name><surname>Bray-Ward</surname><given-names>P</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Zong</surname><given-names>Q</given-names></name><name><surname>Du</surname><given-names>Y</given-names></name><name><surname>Du</surname><given-names>J</given-names></name><name><surname>Driscoll</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Kingsmore</surname><given-names>SF</given-names></name><name><surname>Egholm</surname><given-names>M</given-names></name><name><surname>Lasken</surname><given-names>RS</given-names></name></person-group><article-title>Comprehensive human genome amplification using multiple displacement amplification</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>5261</fpage><lpage>5266</lpage><pub-id pub-id-type="pmid">11959976</pub-id><pub-id pub-id-type="doi">10.1073/pnas.082089499</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>RC</given-names></name><name><surname>Wei</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>KC</given-names></name><name><surname>Mercado</surname><given-names>AB</given-names></name><name><surname>New</surname><given-names>MI</given-names></name></person-group><article-title>Rapid deoxyribonucleic acid analysis by allele-specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene</article-title><source>J Clin Endocrinol Metab</source><year>1995</year><volume>80</volume><fpage>1635</fpage><lpage>1640</lpage><pub-id pub-id-type="pmid">7745011</pub-id><pub-id pub-id-type="doi">10.1210/jc.80.5.1635</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keen-Kim</surname><given-names>D</given-names></name><name><surname>Redman</surname><given-names>JB</given-names></name><name><surname>Alanes</surname><given-names>RU</given-names></name><name><surname>Eachus</surname><given-names>MM</given-names></name><name><surname>Wilson</surname><given-names>RC</given-names></name><name><surname>New</surname><given-names>MI</given-names></name><name><surname>Nakamoto</surname><given-names>JM</given-names></name><name><surname>Fenwick</surname><given-names>RG</given-names></name></person-group><article-title>Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)</article-title><source>J Mol Diagn</source><year>2005</year><volume>7</volume><fpage>236</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">15858147</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baumgartner-Parzer</surname><given-names>SM</given-names></name><name><surname>Nowotny</surname><given-names>P</given-names></name><name><surname>Heinze</surname><given-names>G</given-names></name><name><surname>W&#x000e4;ldhausl</surname><given-names>W</given-names></name><name><surname>Vierhapper</surname><given-names>H</given-names></name></person-group><article-title>Carrier frequency of congenital adrenal hyperplasia (21-hydroxylase deficiency) in a middle European population</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>775</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">15572419</pub-id><pub-id pub-id-type="doi">10.1210/jc.2004-1728</pub-id></citation></ref><ref id="B20"><citation citation-type="other"><article-title>The MHC Haplotype Project</article-title><ext-link ext-link-type="uri" xlink:href="http://www.sanger.ac.uk/HGP/Chr6/MHC/index.shtml"/></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname><given-names>CA</given-names></name><name><surname>Horton</surname><given-names>R</given-names></name><name><surname>Allcock</surname><given-names>RJ</given-names></name><name><surname>Ashurst</surname><given-names>JL</given-names></name><name><surname>Atrazhev</surname><given-names>AM</given-names></name><name><surname>Coggill</surname><given-names>P</given-names></name><name><surname>Dunham</surname><given-names>I</given-names></name><name><surname>Forbes</surname><given-names>S</given-names></name><name><surname>Halls</surname><given-names>K</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Humphray</surname><given-names>SJ</given-names></name><name><surname>Hunt</surname><given-names>S</given-names></name><name><surname>Mungall</surname><given-names>AJ</given-names></name><name><surname>Osoegawa</surname><given-names>K</given-names></name><name><surname>Palmer</surname><given-names>S</given-names></name><name><surname>Roberts</surname><given-names>AN</given-names></name><name><surname>Rogers</surname><given-names>J</given-names></name><name><surname>Sims</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wilming</surname><given-names>LG</given-names></name><name><surname>Elliott</surname><given-names>JF</given-names></name><name><surname>de Jong</surname><given-names>PJ</given-names></name><name><surname>Sawcer</surname><given-names>S</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name><name><surname>Trowsdale</surname><given-names>J</given-names></name><name><surname>Beck</surname><given-names>S</given-names></name></person-group><article-title>Complete MHC haplotype sequencing for common disease gene mapping</article-title><source>Genome Res</source><year>2004</year><volume>14</volume><fpage>1176</fpage><lpage>1187</lpage><pub-id pub-id-type="pmid">15140828</pub-id><pub-id pub-id-type="doi">10.1101/gr.2188104</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>WP</given-names></name><name><surname>Vu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>SS</given-names></name><name><surname>Hansen</surname><given-names>JA</given-names></name><name><surname>Zhao</surname><given-names>LP</given-names></name><name><surname>Geraghty</surname><given-names>DE</given-names></name></person-group><article-title>Toward understanding MHC disease associations: partial resequencing of 46 distinct HLA haplotypes</article-title><source>Genomics</source><year>2006</year><volume>87</volume><fpage>561</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">16434165</pub-id><pub-id pub-id-type="doi">10.1016/j.ygeno.2005.11.020</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>PC</given-names></name><name><surname>Speiser</surname><given-names>PW</given-names></name></person-group><article-title>Congenital adrenal hyperplasia due to 21-hydroxylase deficiency</article-title><source>Endocr Rev</source><volume>21</volume><fpage>245</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">10857554</pub-id><pub-id pub-id-type="doi">10.1210/er.21.3.245</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Curin</surname><given-names>JM</given-names></name><name><surname>Terzic</surname><given-names>J</given-names></name><name><surname>Petkovic</surname><given-names>ZB</given-names></name><name><surname>Zekan</surname><given-names>L</given-names></name><name><surname>Terzic</surname><given-names>IM</given-names></name><name><surname>Susnjara</surname><given-names>IM</given-names></name></person-group><article-title>Lower cortisol and higher ACTH levels in individuals with autism</article-title><source>J Autism Dev Disord</source><year>2003</year><volume>33</volume><fpage>443</fpage><lpage>448</lpage><pub-id pub-id-type="pmid">12959423</pub-id><pub-id pub-id-type="doi">10.1023/A:1025019030121</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tordjman</surname><given-names>S</given-names></name><name><surname>Ferrari</surname><given-names>P</given-names></name><name><surname>Sulmont</surname><given-names>V</given-names></name><name><surname>Duyme</surname><given-names>M</given-names></name><name><surname>Roubertoux</surname><given-names>P</given-names></name></person-group><article-title>Androgenic activity in autism</article-title><source>Am J Psychiatry</source><year>1997</year><volume>154</volume><fpage>1626</fpage><lpage>1627</lpage><pub-id pub-id-type="pmid">9356582</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knickmeyer</surname><given-names>R</given-names></name><name><surname>Baron-Cohen</surname><given-names>S</given-names></name><name><surname>Fane</surname><given-names>BA</given-names></name><name><surname>Wheelwright</surname><given-names>S</given-names></name><name><surname>Mathews</surname><given-names>GA</given-names></name><name><surname>Conway</surname><given-names>GS</given-names></name><name><surname>Brook</surname><given-names>CG</given-names></name><name><surname>Hines</surname><given-names>M</given-names></name></person-group><article-title>Androgens and autistic traits: A study of individuals with congenital adrenal hyperplasia</article-title><source>Horm Behav</source><year>2006</year><volume>50</volume><fpage>148</fpage><lpage>153</lpage><pub-id pub-id-type="pmid">16624315</pub-id><pub-id pub-id-type="doi">10.1016/j.yhbeh.2006.02.006</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Knickmeyer</surname><given-names>R</given-names></name><name><surname>Baron-Cohen</surname><given-names>S</given-names></name><name><surname>Raggatt</surname><given-names>P</given-names></name><name><surname>Taylor</surname><given-names>K</given-names></name></person-group><article-title>Foetal testosterone, social relationships, and restricted interests in children</article-title><source>J Child Psychol Psychiatry</source><year>2005</year><volume>46</volume><fpage>198</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">15679528</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-7610.2004.00349.x</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>RS</given-names></name><name><surname>Mendonca</surname><given-names>BB</given-names></name><name><surname>Barbosa</surname><given-names>AS</given-names></name><name><surname>Lin</surname><given-names>CJ</given-names></name><name><surname>Marcondes</surname><given-names>JA</given-names></name><name><surname>Billerbeck</surname><given-names>AE</given-names></name><name><surname>Bachega</surname><given-names>TA</given-names></name></person-group><article-title>Microconversion between CYP21A2 and CYP21A1P promoter regions causes the nonclassical form of 21-hydroxylase deficiency</article-title><source>J Clin Endocrinol Metab</source><year>2007</year><volume>92</volume><fpage>4028</fpage><lpage>4034</lpage><pub-id pub-id-type="pmid">17666484</pub-id><pub-id pub-id-type="doi">10.1210/jc.2007-1245</pub-id></citation></ref></ref-list></back></article> 